Table 2

Baseline procedural characteristics

Cohort B
(n=662)
Cohort H
(n=629)
P value
Access site, n (%)
  Femoral131 (19.8%)79 (12.6%)<0.01
Culprit lesion, n (%)0.60
  LMS16 (2.2%)24 (3.4%)0.18
  LAD270 (37.8%)272 (38.9%)0.91
  LCx127 (17.8%)126 (18.0%)0.92
  RCA289 (40.5%)264 (37.7%)0.29
  Graft12 (1.7%)14 (2.0%)0.66
Number of bystander lesions (n %)*390 (35.3%)308 (30.6%)0.02
Number of lesions attempted (n %)*822 (74.5%)834 (82.7%)<0.01
Number of stents per patient, mean (SD)1.3±0.81.4±0.90.01
Drug eluting stent, (n %)†815 (95.5%)866 (97.6%)0.02
Stent diameter, mean (SD)3.3±0.73.4±1.50.11
Stent length, mean (SD)27.1±10.227.8±11.20.09
TIMI flow in the culprit artery at the end of the procedure, n (%)‡:0.17
  0–120 (2.8%)12 (1.7%)
  2–3694 (97.2%)688 (98.3%)
Number of lesions successful, n (%)§:793 (96.5%)799 (95.8%)0.48
Use of a thrombus extraction catheter, n (%):297 (44.9%)78 (12.4%)<0.01
Use of a vascular closure device system, n (%)¶:107 (81.7%)76 (96.2%)<0.01
Thrombotic procedural complications, n (%):21 (3.17%)13 (2.07%)0.22
  • If more than one stent is used, the stent length denotes the sum of all stent lengths.

  • LAD, left anterior descending coronary artery; LCx, left circumflex coronary artery; LMS, left main stem; RCA,right coronary artery.